Those readers who were around 10 years ago are likely to have stark memories of Severe Acute Respiratory Syndrome, or SARS, the disease that struck fear into Asia's communities and temporarily laid waste to economies. Needless to say, private equity and venture capital investment during this period was pretty much nil.
PE executives, some never happier than when boarding a plane in search of the next big investment, found themselves grounded, as did peers in other industries. The chances of contamination were much higher...
Timothy Zee, a Singapore-based managing director with PAG whose primary responsibilities included deal sourcing and business development, has left the firm after 10 years.
Bertelsmann India Investments has earmarked USD 500m, provided by its eponymous German parent, for investment in local start-ups. The VC unit’s total deployment since its launch in 2013 is USD 285m.
UK-headquartered incubator Entrepreneur First (EF) has raised USD 158m, targeted in part at investment in Southeast Asian start-ups and expanding its reach in the region.
CDH Investments has agreed to sell New Zealand-based supplements manufacturer The Better Health Company (TBHC) to Nestlé Health Science for an undisclosed sum.